GT
TMO icon

Greenleaf Trust’s Thermo Fisher Scientific TMO Stock Holding History

Greenleaf Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Sell
10,430
-469
-4% -$225K 0.05% 106
2026
Q1 		$5.36M Sell
10,899
-280
-3% -$152K 0.05% 98
2025
Q4 		$6.48M Buy
11,179
+184
+2% +$104K 0.06% 86
2025
Q3 		$5.33M Buy
10,995
+617
+6% +$287K 0.05% 97
2025
Q2 		$4.21M Sell
10,378
-2,005
-16% -$838K 0.04% 114
2025
Q1 		$6.16M Buy
12,383
+92
+0.7% +$49.8K 0.06% 88
2024
Q4 		$6.39M Sell
12,291
-115
-0.9% -$63.2K 0.06% 91
2024
Q3 		$7.67M Buy
12,406
+115
+0.9% +$68.1K 0.07% 81
2024
Q2 		$6.8M Buy
12,291
+210
+2% +$120K 0.06% 83
2024
Q1 		$7.02M Buy
12,081
+1,246
+11% +$699K 0.07% 83
2023
Q4 		$5.75M Sell
10,835
-1,823
-14% -$882K 0.06% 91
2023
Q3 		$6.41M Sell
12,658
-98
-0.8% -$52.2K 0.07% 76
2023
Q2 		$6.66M Sell
12,756
-711
-5% -$384K 0.07% 77
2023
Q1 		$7.76M Buy
13,467
+443
+3% +$250K 0.09% 70
2022
Q4 		$7.17M Buy
13,024
+947
+8% +$502K 0.09% 72
2022
Q3 		$6.13M Buy
12,077
+59
+0.5% +$33K 0.09% 70
2022
Q2 		$6.53M Buy
12,018
+808
+7% +$445K 0.1% 58
2022
Q1 		$6.62M Sell
11,210
-147
-1% -$84.4K 0.08% 55
2021
Q4 		$7.58M Buy
11,357
+672
+6% +$420K 0.09% 55
2021
Q3 		$6.11M Buy
10,685
+275
+3% +$151K 0.07% 58
2021
Q2 		$5.25M Sell
10,410
-219
-2% -$103K 0.07% 66
2021
Q1 		$4.85M Buy
10,629
+366
+4% +$175K 0.06% 70
2020
Q4 		$4.78M Buy
10,263
+201
+2% +$94.2K 0.06% 68
2020
Q3 		$4.44M Sell
10,062
-93
-0.9% -$38.4K 0.07% 61
2020
Q2 		$3.68M Buy
10,155
+340
+3% +$114K 0.06% 68
2020
Q1 		$2.78M Buy
9,815
+65
+0.7% +$20.5K 0.06% 71
2019
Q4 		$3.17M Buy
9,750
+153
+2% +$46.4K 0.05% 75
2019
Q3 		$2.79M Buy
9,597
+425
+5% +$122K 0.04% 77
2019
Q2 		$2.69M Sell
9,172
-96
-1% -$26.4K 0.04% 81
2019
Q1 		$2.54M Buy
9,268
+506
+6% +$126K 0.04% 80
2018
Q4 		$1.96M Buy
8,762
+306
+4% +$71.8K 0.04% 91
2018
Q3 		$2.06M Buy
8,456
+258
+3% +$59.4K 0.04% 95
2018
Q2 		$1.7M Buy
8,198
+894
+12% +$190K 0.03% 102
2018
Q1 		$1.51M Sell
7,304
-223
-3% -$46.8K 0.03% 110
2017
Q4 		$1.43M Buy
7,527
+265
+4% +$50.8K 0.03% 121
2017
Q3 		$1.37M Buy
7,262
+1,113
+18% +$202K 0.03% 121
2017
Q2 		$1.07M Buy
6,149
+92
+2% +$15.5K 0.02% 129
2017
Q1 		$930K Buy
6,057
+155
+3% +$23.7K 0.02% 109
2016
Q4 		$833K Sell
5,902
-47
-0.8% -$6.93K 0.02% 101
2016
Q3 		$946K Buy
5,949
+696
+13% +$107K 0.02% 93
2016
Q2 		$776K Sell
5,253
-250
-5% -$36.9K 0.02% 94
2016
Q1 		$779K Sell
5,503
-90
-2% -$12.1K 0.02% 95
2015
Q4 		$793K Buy
5,593
+166
+3% +$22.1K 0.02% 92
2015
Q3 		$664K Hold
5,427
– – 0.02% 92
2015
Q2 		$704K Hold
5,427
– – 0.02% 94
2015
Q1 		$729K Hold
5,427
– – 0.02% 95
2014
Q4 		$680K Sell
5,427
-160
-3% -$19.5K 0.02% 96
2014
Q3 		$680K Sell
5,587
-329
-6% -$40K 0.02% 93
2014
Q2 		$698K Sell
5,916
-200
-3% -$23.5K 0.02% 96
2014
Q1 		$735K Buy
6,116
+53
+0.9% +$6.3K 0.02% 92
2013
Q4 		$675K Buy
6,063
+160
+3% +$15.9K 0.02% 99
2013
Q3 		$544K Buy
5,903
+6
+0.1% +$543 0.02% 104
2013
Q2 		$499K Buy
+5,897
New +$491K 0.02% 109

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Greenleaf Trust's TMO Position: Q2 2026 in Review

Greenleaf Trust reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, selling an estimated $225K and leaving 10,430 shares worth $5.23M. The position accounts for 0.05% of the portfolio, ranked #106.

Greenleaf Trust first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.76M in Q1 2023. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Greenleaf Trust held 10,430 shares of Thermo Fisher Scientific worth $5.23M as of Q2 2026.
  • Greenleaf Trust sold 469 Thermo Fisher Scientific shares in Q2 2026, an estimated $225K.
  • Thermo Fisher Scientific made up 0.05% of Greenleaf Trust's portfolio in Q2 2026, its #106 holding.
  • Greenleaf Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Greenleaf Trust's Thermo Fisher Scientific position peaked at $7.76M in Q1 2023.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.